Foxk1 and Foxk2 promote cardiomyocyte proliferation and heart regeneration

Dongcheng Cai, Chungeng Liu, Haotong Li, Chiyin Wang, Lina Bai, Jie Feng, Miaoqing Hu, Hao Wang, Shen Song, Yifan Xie, Ziwei Chen, Jiajun Zhong, Hong Lian, Zhiwei Yang, Yuhui Zhang and Yu Nie ()
Additional contact information
Dongcheng Cai: Chinese Academy of Medical Sciences and Peking Union Medical College
Chungeng Liu: Chinese Academy of Medical Sciences and Peking Union Medical College
Haotong Li: Chinese Academy of Medical Sciences and Peking Union Medical College
Chiyin Wang: Chinese Academy of Medical Sciences and Peking Union Medical College
Lina Bai: Chinese Academy of Medical Sciences and Peking Union Medical College
Jie Feng: Chinese Academy of Medical Sciences and Peking Union Medical College
Miaoqing Hu: Chinese Academy of Medical Sciences and Peking Union Medical College
Hao Wang: Chinese Academy of Medical Sciences and Peking Union Medical College
Shen Song: Chinese Academy of Medical Sciences and Peking Union Medical College
Yifan Xie: Chinese Academy of Medical Sciences and Peking Union Medical College
Ziwei Chen: Chinese Academy of Medical Sciences and Peking Union Medical College
Jiajun Zhong: Chinese Academy of Medical Sciences and Peking Union Medical College
Hong Lian: Chinese Academy of Medical Sciences and Peking Union Medical College
Zhiwei Yang: Chinese Academy of Medical Sciences and Peking Union Medical College
Yuhui Zhang: Chinese Academy of Medical Sciences and Peking Union Medical College
Yu Nie: Chinese Academy of Medical Sciences and Peking Union Medical College

Nature Communications, 2025, vol. 16, issue 1, 1-17

Abstract: Abstract Promoting endogenous cardiomyocyte proliferation is a promising strategy for cardiac repair. Identifying key factors that regulate cardiomyocyte proliferation can advance the development of novel therapies for heart regeneration. Here, we identify Foxk1 and Foxk2 as key regulators of cardiomyocyte proliferation, whose expression declines during postnatal heart development. Cardiomyocyte-specific knockout of Foxk1 or Foxk2 impairs neonatal heart regeneration after myocardial infarction (MI) injury. AAV9-mediated Foxk1 or Foxk2 overexpression extends the postnatal cardiomyocyte proliferative window and enhances cardiac repair in adult mice after MI. Mechanistically, Foxk1 and Foxk2 drive cardiomyocyte cell cycle progression by directly activating CCNB1 and CDK1 expression, forming the CCNB1/CDK1 complex that facilitates G2/M transition. Moreover, Foxk1 and Foxk2 promote cardiomyocyte proliferation by upregulating HIF1α expression, which enhances glycolysis and the pentose phosphate pathway (PPP), which further favors cardiomyocyte proliferation. These findings establish Foxk1 and Foxk2 as promising therapeutic targets for cardiac injury.

Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-025-57996-z Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-57996-z

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-025-57996-z

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().